CODX vs NEM · rev $3.9M vs P/E 14, rev $22.67B
Co-Diagnostics, Inc. Common Stock (CODX) versus Newmont Goldcorp Corp (NEM) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Newmont Goldcorp Corp (NEM) is a gold company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported NEM revenue for 2025-12-31 was $22.67B. Net income was $7.08B. Revenue was up 21.3% from 2024-12-31 to 2025-12-31. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
CODX currently screens at market cap $31.4M. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
Not investment advice. Open the CODX and NEM stock pages for the full models.
Not investment advice.